We are live on ! Find out more
SCM

Stellar Capital Management Portfolio holdings

AUM $147M
1-Year Est. Return 5.91%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+5.91%
3 Year Est. Return
+23.45%
5 Year Est. Return
10 Year Est. Return
AUM
$103M
AUM Growth
+$10.1M
Cap. Flow
+$11.7M
Cap. Flow %
11.38%
Top 10 Hldgs %
31.8%
Holding
68
New
4
Increased
52
Reduced
5
Closed
1

Sector Composition

1 Technology 15.83%
2 Healthcare 13.98%
3 Industrials 12.78%
4 Energy 8.46%
5 Financials 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
1
Intel
INTC
$478B
$4.11M 4%
131,486
+4,919
+4% +$166K
MRK icon
2
Merck
MRK
$315B
$3.63M 3.53%
66,207
+3,391
+5% +$192K
EFA icon
3
iShares MSCI EAFE ETF
EFA
$76.5B
$3.58M 3.48%
55,831
+10,292
+23% +$648K
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$3.51M 3.41%
16,992
+1,902
+13% +$393K
BLK icon
5
Blackrock
BLK
$166B
$3.45M 3.35%
9,420
+600
+7% +$217K
VWO icon
6
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$3.39M 3.29%
82,884
+10,276
+14% +$418K
JNJ icon
7
Johnson & Johnson
JNJ
$609B
$2.95M 2.86%
29,282
+4,790
+20% +$487K
GE icon
8
GE Aerospace
GE
$364B
$2.86M 2.78%
24,024
+3,665
+18% +$436K
GOOG icon
9
Alphabet (Google) Class C
GOOG
$4.22T
$2.67M 2.6%
97,306
+7,219
+8% +$193K
TWX
10
DELISTED
Time Warner Inc
TWX
$2.58M 2.51%
30,569
+2,275
+8% +$189K
XOM icon
11
ExxonMobil
XOM
$611B
$2.54M 2.46%
29,841
+5,550
+23% +$492K
VGK icon
12
Vanguard FTSE Europe ETF
VGK
$30B
$2.49M 2.42%
45,925
+7,735
+20% +$417K
TMO icon
13
Thermo Fisher Scientific
TMO
$198B
$2.46M 2.39%
18,340
-70
-0.4% -$9.02K
MHK icon
14
Mohawk Industries
MHK
$6.8B
$2.45M 2.38%
13,210
+910
+7% +$157K
BAC icon
15
Bank of America
BAC
$430B
$2.4M 2.34%
156,153
+13,275
+9% +$213K
ETN icon
16
Eaton
ETN
$155B
$2.38M 2.32%
35,069
+3,329
+10% +$226K
PG icon
17
Procter & Gamble
PG
$349B
$2.32M 2.25%
28,309
+1,500
+6% +$129K
DGX icon
18
Quest Diagnostics
DGX
$23.3B
$2.29M 2.23%
29,840
+1,845
+7% +$132K
VOD icon
19
Vodafone
VOD
$36.2B
$2.23M 2.17%
68,294
+2,964
+5% +$102K
PAYX icon
20
Paychex
PAYX
$40.7B
$2.23M 2.17%
44,955
+3,095
+7% +$150K
MET icon
21
MetLife
MET
$60.5B
$2.23M 2.16%
49,408
+5,110
+12% +$230K
ORCL icon
22
Oracle
ORCL
$364B
$2.13M 2.07%
49,342
+4,110
+9% +$178K
ACN icon
23
Accenture
ACN
$87.9B
$2.13M 2.07%
22,714
+990
+5% +$88.4K
MSFT icon
24
Microsoft
MSFT
$2.93T
$2.12M 2.06%
52,067
+3,766
+8% +$164K
CVX icon
25
Chevron
CVX
$373B
$1.93M 1.87%
18,344
+8,416
+85% +$898K

Similar funds

Stellar Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Stellar Capital Management held 68 positions worth $103M, up 11% from $92.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Stellar Capital Management deployed $11.7M of net new capital in Q1 2015, opening 4 new positions and adding to 52 existing holdings. Its largest new stake was Gilead Sciences: 12,322 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $793K trimmed.

  • Stellar Capital Management's largest Q1 2015 buy was Gilead Sciences: 12,322 shares worth $1.21M.
  • Stellar Capital Management added most to Chevron in Q1 2015, an estimated $898K increase.
  • Stellar Capital Management's biggest Q1 2015 reduction was Edwards Lifesciences, cutting an estimated $793K.
  • Stellar Capital Management fully exited UGI in Q1 2015, selling an estimated $203K.
  • Stellar Capital Management's ten largest holdings make up 32% of its $103M portfolio in Q1 2015.
  • Stellar Capital Management opened 4 new positions and closed 1 in Q1 2015.
  • Stellar Capital Management's portfolio value rose 11% quarter-over-quarter to $103M.

Based on Stellar Capital Management's 13F filing for Q1 2015, filed 27 Apr 2015.